Elequin Capital’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,857
Closed -$41K 212
2025
Q2
$41K Buy
2,857
+1,962
+219% +$27.3K 0.01% 267
2025
Q1
$13K Buy
+895
New +$13.5K ﹤0.01% 277
2024
Q1
Sell
-29,152
Closed -$408K 298
2023
Q4
$408K Buy
29,152
+12,194
+72% +$166K 0.12% 57
2023
Q3
$232K Sell
16,958
-3,224
-16% -$45.6K 0.05% 99
2023
Q2
$285K Buy
20,182
+9,577
+90% +$139K 0.15% 66
2023
Q1
$156K Buy
10,605
+8,775
+480% +$133K 0.11% 67
2022
Q4
$28.4K Buy
+1,830
New +$27.8K 0.01% 362

Other funds holding DIAX

Elequin Capital's DIAX Position: Q3 2025 in Review

Elequin Capital sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q3 2025, closing a stake of 2,857 shares — an estimated $41K sold.

Elequin Capital first reported a position in DIAX in Q4 2022 and held it in 7 quarters. The position peaked at $408K in Q4 2023. 109 funds tracked by Wall St. Rank hold DIAX as of Q3 2025.

  • Elequin Capital reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q3 2025 after selling out during the quarter.
  • Elequin Capital sold 2,857 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q3 2025, an estimated $41K.
  • Elequin Capital first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q4 2022 and held it in 7 quarters.
  • Elequin Capital's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $408K in Q4 2023.
  • 109 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q3 2025.

Based on Elequin Capital's 13F filing for Q3 2025, filed 14 Nov 2025.